| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology II, Nara Medical University, Kashihara, Nara, Japan; Thoracic-Cardiovascular Surgery, Nara Medical University, Kashihara, Nara, Japan
2 Department of Physiology II, Nara Medical University, Kashihara, Nara, Japan
3 Department of Neurology and Neurosurgery, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan
4 Thoracic-Cardiovascular Surgery, Nara Medical University, Kashihara, Nara, Japan
* To whom correspondence should be addressed. E-mail: mtakaki{at}naramed-u.ac.jp.
We hypothesized that calpain inhibitor-1 protected left ventricular function from ischemic-reperfusion injury by inhibiting the proteolysis of 
-fodrin. To test this hypothesis, we investigated the effect of calpain inhibitor-1 on left ventricular mechanical work and
energetics in the cross-circulated rat hearts underwent 15-min global ischemia and 60-min reperfusion (n=9). After ischemic-reperfusion with calpain inhibitor-1, mean end-systolic pressure at midrange left ventricular volume (ESPmLVV) and systolic pressure-volume area
(PVA) at midrange left ventricular volume (PVAmLVV: a total mechanical energy per beat) were hardly changed, although they were significantly (P<0.01) decreased after ischemic-reperfusion without calpain inhibitor-1. Mean myocardial oxygen consumption per beat (VO2) intercepts
(PVA-independent VO2; VO2 for the total Ca2+ handling in excitation-contraction coupling and basal metabolism) of VO2-PVA linear relations were also unchanged after ischemic-reperfusion with calpain inhibitor-1, although they were significantly (P<0.01) decreased after ischemic-reperfusion without calpain inhibitor-1. There were no significant differences in O2 costs of left ventricular PVA and contractility among the hearts in control (or normal), post ischemic-reperfusion and post ischemic-reperfusion with calpain inhibitor-1. Western blotting of -fodrin and the immunostaining of 150-kD products of -fodrin confirmed that calpain
inhibitor-1 almost completely protected proteolysis of -fodrin. Our results indicate that calpain
inhibitor-1 prevents the heart from ischemic-reperfusion injury associated with the impairment of total calcium handling by directly inhibiting the proteolysis of -fodrin.
This article has been cited by other articles:
|
|
 |
|
  C. Nakajima-Takenaka, G.-X. Zhang, K. Obata, K. Tohne, H. Matsuyoshi, Y. Nagai, A. Nishiyama, and M. Takaki Left ventricular function of isoproterenol-induced hypertrophied rat hearts perfused with blood: mechanical work and energetics Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1736 - H1743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, Y. Li, L. Shan, E Shen, R. Chen, and T. Peng Over-expression of calpastatin inhibits calpain activation and attenuates myocardial dysfunction during endotoxaemia Cardiovasc Res, July 1, 2009; 83(1): 72 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takewa, E. R. Chemaly, M. Takaki, L. F. Liang, H. Jin, I. Karakikes, C. Morel, Y. Taenaka, E. Tatsumi, and R. J. Hajjar Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1117 - H1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tsuji, F. del Monte, Y. Yoshikawa, T. Abe, J. Shimizu, C. Nakajima-Takenaka, S. Taniguchi, R. J. Hajjar, and M. Takaki Rescue of Ca2+ overload-induced left ventriclur dysfunction by targeted ablation of phospholamban Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H310 - H317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. French, K. L. Hamilton, J. C. Quindry, Y. Lee, P. A. Upchurch, and S. K. Powers Exercise-induced protection against myocardial apoptosis and necrosis: MnSOD, calcium-handling proteins, and calpain FASEB J, August 1, 2008; 22(8): 2862 - 2871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jung, A. S. Martins, E. Niggli, and N. Shirokova Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways Cardiovasc Res, March 1, 2008; 77(4): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. French, J. C. Quindry, D. J. Falk, J. L. Staib, Y. Lee, K. K. W. Wang, and S. K. Powers Ischemia-reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H128 - H136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Nakajima-Takenaka, S. Sakata, S. Kato, Y. Ohga, K.-y. Murata, S. Taniguchi, and M. Takaki Detrimental effects after dobutamine infusion on rat left ventricular function: mechanical work and energetics Exp Physiol, July 1, 2005; 90(4): 635 - 644. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
